Detalhe da pesquisa
1.
Attempted replication of pharmacogenetic association of variants in PPP1R14C and CCDC148 with aromatase inhibitor-induced musculoskeletal symptoms.
Pharmacogenet Genomics
; 34(4): 126-129, 2024 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38359166
2.
Thymidine kinase activity levels in serum can identify HR+ metastatic breast cancer patients with a low risk of early progression (SWOG S0226).
Biomarkers
; 28(3): 313-322, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36647745
3.
Androgen and oestrogen receptor co-expression determines the efficacy of hormone receptor-mediated radiosensitisation in breast cancer.
Br J Cancer
; 127(5): 927-936, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35618789
4.
Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.
Support Care Cancer
; 30(10): 8059-8067, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35776183
5.
Osteonecrosis of the jaw risk factors in bisphosphonate-treated patients with metastatic cancer.
Oral Dis
; 28(1): 193-201, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33274559
6.
Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.
Pharmacogenet Genomics
; 31(5): 116-123, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34096894
7.
Targeted degradation of activating estrogen receptor α ligand-binding domain mutations in human breast cancer.
Breast Cancer Res Treat
; 180(3): 611-622, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32067153
8.
Correction to: Targeted degradation of activating estrogen receptor α ligand-binding domain mutations in human breast cancer.
Breast Cancer Res Treat
; 180(3): 623, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32180072
9.
Genetic variation in EPHA contributes to sensitivity to paclitaxel-induced peripheral neuropathy.
Br J Clin Pharmacol
; 86(5): 880-890, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31823378
10.
Exemestane may be less detrimental than letrozole to bone health in women homozygous for the UGT2B17*2 gene deletion.
Breast Cancer Res Treat
; 175(2): 297-303, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30747308
11.
Pazopanib with low fat meal (PALM) in advanced renal cell carcinoma.
Invest New Drugs
; 37(2): 323-330, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30393825
12.
Attempted replication of SNPs in RANKL and OPG with musculoskeletal adverse events during aromatase inhibitor treatment for breast cancer.
Physiol Genomics
; 50(2): 98-99, 2018 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29212847
13.
Cytochrome P-450 2D6 (CYP2D6) Genotype and Breast Cancer Recurrence in Tamoxifen-Treated Patients: Evaluating the Importance of Loss of Heterozygosity.
Am J Epidemiol
; 185(2): 75-85, 2017 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27988492
14.
Variable aromatase inhibitor plasma concentrations do not correlate with circulating estrogen concentrations in post-menopausal breast cancer patients.
Breast Cancer Res Treat
; 165(3): 659-668, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28643023
15.
Effects of exemestane and letrozole therapy on plasma concentrations of estrogens in a randomized trial of postmenopausal women with breast cancer.
Breast Cancer Res Treat
; 161(3): 453-461, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27943008
16.
ESR1 and PGR polymorphisms are associated with estrogen and progesterone receptor expression in breast tumors.
Physiol Genomics
; 48(9): 688-98, 2016 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27542969
17.
Patient-Reported Outcomes and Early Discontinuation in Aromatase Inhibitor-Treated Postmenopausal Women With Early Stage Breast Cancer.
Oncologist
; 21(5): 539-46, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27009936
18.
The CYP17A1 inhibitor abiraterone exhibits estrogen receptor agonist activity in breast cancer.
Breast Cancer Res Treat
; 157(1): 23-30, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27083183
19.
Fulvestrant decreases anastrozole drug concentrations when taken concurrently by patients with metastatic breast cancer treated on SWOG study S0226.
Br J Clin Pharmacol
; 81(6): 1134-41, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26859101
20.
Pharmacogenetic Predictors of Response.
Adv Exp Med Biol
; 882: 191-215, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26987536